Clinical Trial Update: Efficacy of Oral Supplementation With Magnesium to Reduce Febrile Neutropenia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether oral magnesium supplementation can reduce febrile neutropenia. The snippet indicates the status as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Drugs mentioned

• Magnesium (magnesium)

Snippet

Sponsor: Universidad Nacional Autonoma de Mexico | Conditions: Febrile Neutropenia | Phase 2 | Status: UNKNOWN